<DOC>
	<DOCNO>NCT02985801</DOCNO>
	<brief_summary>Does pancreas enzyme replacement ( PERT ) decrease weight loss improve quality life patient unresectable pancreatic cancer ?</brief_summary>
	<brief_title>PERT Treatment Exocrine Pancreatic Insufficiency Patients With Unresectable Pancreatic Cancer</brief_title>
	<detailed_description>Randomized , double-blind clinical trial aim assess impact pancreas enzyme replacement therapy weight loss quality life . Prevalence pancreatic exocrine insufficiency ( PEI ) determine fecal elastase-1 test ( FE1 ) patient unresectable pancreatic cancer , without evidence pancreatic duct ( PD ) common bile duct ( CBD ) obstruction base MRI / endoscopic ultrasound ( EUS ) . Patients PEI ( FE1 &lt; 200 ) receive Pertzye placebo cross-over fashion , 4 week . Body weight , body mass index ( BMI ) , body composition ( Bioimpedance ) , measure time diagnosis PEI 4 10 week cross-over treatment . Baseline measurement Vitamin D-25 , Vitamin A , iron ( ferritin , total iron binding capacity ( TIBC ) , iron ) , Vitamin B12 , Tissue transglutaminase IgA ( tTG ) total Immunoglobulin A ( IgA ) . Quality Life ( pain , diarrhea , weight , bloating , etc . ) assess 0,4,10 week Functional Assessment Cancer Therapy patient liver , bile duct pancreas cancer ( FACT-Hep ) physical , social , emotional , functional quality life .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Patients 1880 year Underlying pancreatic adenocarcinoma , unresectable ( local invasion distant metastasis ) On establish chemotherapy regimen pancreas cancer , continue time study Fecal elastase1 test ( FE1 ) less 200 mcg pancreatic elastase/g stool Common bile duct obstruction result obstructive jaundice Celiac disease Crohn 's disease Benign pancreatic condition Bowel obstruction Surgically alter bowel anatomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>